BIOWKS Bio-Works Technologies AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · bio-works.com

3.030SEK-0.98%Mkt Cap: 29.39M $P/E: 76.504d ago

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activa…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap29.39M USD

Enterprise Value26.40M USD

Revenue (TTM)8.58M USD

Gross Profit4.57M USD

Net Income (TTM)-1.46M USD

Revenue/Share0.96 SEK

Last Price3.030 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees32

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)76.50

P/E (Forward)5.02

PEG—

EV/EBITDA-193.95

EV/Revenue3.08

P/S3.43

P/B5.76

EPS (TTM)0.01

EPS (Forward)0.61

52W Range

2.03034% of range4.980

52W High4.980 SEK

52W Low2.030 SEK

Profitability

Gross Margin76.48%

Oper. Margin-15.93%

EBITDA Margin-1.59%

Profit Margin-24.39%

ROE-30.99%

ROA-21.55%

Growth

Revenue Growth52.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.80M USD

CapEx (TTM)38.64K USD

FCF Margin-24.09%

FCF Yield-7.03%

Net Debt-2.87M USD

Net Debt/EBITDA21.11

Balance Sheet

Debt/Equity—

Current Ratio6.88

Quick Ratio4.68

Book Value/Sh0.53 SEK

Cash/Share0.30 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.100.41M

Float46.39M

Insiders50.92%

Institutions12.04%

Technical

SMA 503.301 (-8.2%)

SMA 2003.244 (-6.6%)

Beta0.63

S&P 52W Chg14.58%

Avg Vol (30d)40.73K

Avg Vol (10d)52.22K

Technical Indicators

RSI (14)38.9

MACD-0.0503

MACD Signal-0.0329

MACD Hist.-0.0174

BB Upper3.436 SEK

BB Middle3.241 SEK

BB Lower3.046 SEK

BB Width12.05%

ATR (14)0.2041 SEK

Vol Ratio (20d)5.42x